Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.
Rice, Simon M., Hickie, Ian B., Yung, Alison R., Mackinnon, Andrew, Berk, Michael, Davey, Christopher, Hermens, Daniel F., Hetrick, Sarah E., Parker, Alexandra G., Schäfer, Miriam R., McGorry, Patrick D. and Amminger, G. Paul 2016, Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial., Early intervention in psychiatry, vol. 10, no. 4, pp. 290-299, doi: 10.1111/eip.12166.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.
US authorities have recommended 'black-box' warnings for antidepressants because of the increased risk of suicidality for individuals up to age 25. There is thus a clinical and ethical imperative to provide effective treatment for youth depression with an acceptable risk-benefit balance. Long-chain omega-3 polyunsaturated fatty acids (PUFAs) play an important role in a range of physiological processes in living organisms. Supplementation with omega-3 PUFAs has been shown to have a range of beneficial effects on both physical and mental health, and results of previous trials suggest that omega-3 PUFAs may be a safe and effective treatment for depression. However, conclusions from these trials have been limited by their relatively small sample sizes.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.